XML 57 R45.htm IDEA: XBRL DOCUMENT v3.25.4
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense
The following table presents share-based compensation expense and the related tax benefits for the periods indicated:
Year Ended December 31,
($ in thousands)202520242023
Share-based compensation expense related to:
Stock options$294 $283 $143 
Restricted stock awards679 221 345 
Total share-based compensation expense$973 $504 $488 
Related tax benefits$254 $119 $112 
The following table presents unrecognized share-based compensation expense as of the date indicated:
December 31, 2025
($ in thousands)Unrecognized ExpenseWeighted-Average Remaining Expected Recognition Period
Unrecognized share-based compensation expense related to:
Stock options$246 1.1 years
Restricted stock awards1,718 2.8 years
Total unrecognized share-based compensation expense$1,964 2.6 years
Schedule of Stock Options
The following table represents stock option activity as of and for the period indicated:
Year Ended December 31, 2025
($ in thousands except per share data)
Number of SharesWeighted-Average Exercise Price Per ShareWeighted-Average Contractual TermAggregated Intrinsic Value
Outstanding at beginning of year
576,412 $14.20 5.01 years$3,481 
Exercised
(206,732)$11.02 1.08 years
Balance at end of year369,680 $15.98 5.73 years$2,097 
Exercisable at end of year271,361 $15.91 5.08 years$1,558 
The following table represents information regarding unvested stock options for the period indicated:
Year Ended December 31, 2025
Number of SharesWeighted-Average Exercise Price Per Share
Outstanding at beginning of year
179,659 $15.93 
Vested
(81,340)$15.66 
Balance at end of year98,319 $16.16 
The following table presents information related to the stock option plan for the periods indicated:
Year Ended December 31,
($ in thousands, except per share data)202520242023
Intrinsic value of options exercised
$1,865 $247 $883 
Cash received from options exercised
$2,278 $353 $1,350 
Tax benefit from options exercised
$89 $14 $103 
Weighted-average estimated fair value per share of options granted
$— $4.15 $3.14 
Schedule of Weighted-Average Assumptions of Stock Options
The following table presents the weighted-average assumptions used to determine the fair value of options granted for the periods indicated:
Year Ended December 31,
20242023
Risk-free interest rate
3.89 %4.92 %
Expected term
6.80 years6.04 years
Expected stock price volatility
29.45 %28.76 %
Dividend yield
3.95 %4.79 %
Schedule of Restricted Stock Awards
The following table represents RSAs activity for the year ended December 31, 2025:
Year Ended December 31, 2025
Number of SharesWeighted-Average Grant Date Fair Value Per Share
Outstanding at beginning of period
119,100 $20.40 
Granted
6,200 $21.91 
Vested
(32,950)$20.36 
Forfeited
(1,500)$20.65 
Outstanding at end of period90,850 $20.52